1st Quarter - Report

SLC HEALTH STRATEGIES, LLC for EISAI INC.

Firm
Client
Income
$40,500
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

HR 2., "Medicare Access and CHIP Reauthorization Act of 2015" S. 810, "SGR Repeal and Medicare Provider Payment Modernization Act of 2015" The Treat and Reduce Obesity Act of 2015 (no bill number yet) -- Medicare coverage of FDA-approved obesity medications In the above measures, specifically potential pharmaceutical reimbursement cuts as potential offsets as well as Medicare coverage for FDA-approved obesity medications.

LobbyistCovered position, as disclosed
SHARON COHEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2 (114th), S. 810 (114th)

Budget/Appropriations BUD

H. Con. Res. 27, "Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025" S. Con. Res. 11, "An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025." In the above, specifically potential pharmaceutical reimbursement cuts as potential offsets AND potential inclusion of Medicare coverage of FDA-approved obesity drugs. Department of Defense Appropriations Act, 2016 (no bill number yet), specifically DoD/TRICARE coverage of FDA-approved obesity drugs.

LobbyistCovered position, as disclosed
SHARON COHEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S.Con.Res. 11 (114th), H.Con.Res. 27 (114th)

Pharmacy PHA

Obesity product matters HR 639/S. 481 --Improving Regulatory Transparency for New Medical Therapies Act re: DEA scheduling of controlled substances

LobbyistCovered position, as disclosed
SHARON COHEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 639 (114th), S. 481 (114th)

Defense DEF

Department of Defense Appropriations Act, 2016 (no bill number yet), specifically DoD/TRICARE coverage of FDA-approved obesity drugs. National Defense Authorization Act, 2016 (no bill number yet), specifically DoD/TRICARE coverage of FDA-approved obesity drugs.

LobbyistCovered position, as disclosed
SHARON COHEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.